Metagenomi
MGX

Metagenomi (MGX) earnings history

Most recent quarter

Period end
Jun 30, 2025
EPS actual
−$0.54
EPS estimate
−$0.62
Revenue
$8.5M
Reported
Aug 12, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2025Aug 12, 2025−$0.62−$0.54+12.76%$8.5MSEC
Q1 2025May 13, 2025−$0.61−$0.68−11.75%$4.1MSEC
Q4 2024Mar 17, 2025−$0.75−$0.37+50.59%$9.6MSEC
Q2 2024Aug 14, 2024−$0.65−$0.29+55.62%$20.0MSEC

Quarterly revenue

Q2 2024
$20.0M
Q4 2024
$9.6M
Q1 2025
$4.1M
Q2 2025
$8.5M

Frequently asked questions

  • When did Metagenomi (MGX) last report earnings?

    Metagenomi last reported on Aug 12, 2025, covering fiscal Q2 2025.

  • Did MGX beat earnings estimates?

    Yes. Metagenomi reported EPS of −$0.54 for Q2 2025 against a −$0.62 estimate — a 12.76% beat.

  • How much revenue did MGX report last quarter?

    Metagenomi reported $8.5M in revenue for Q2 2025, against a consensus estimate of $8.5M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.